(Q47887130)

English

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.

scientific article published in October 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652559

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group. (English)

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652559

1 reference

based on heuristic

inferred from title

author name string

B Nashan

1

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652559

R Moore

2

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652559

P Amlot

3

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652559

A G Schmidt

4

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652559

K Abeywickrama

5

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652559

J P Soulillou

6

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652559

language of work or name

0 references

publication date

1 October 1997

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652559

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652559

350

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652559

1193-1198

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652559

9086

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652559

The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Early versus late acute renal allograft rejection: impact on chronic rejection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of an acute rejection episode on long-term renal allograft survival (t1/2)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Relevant targets for therapy with monoclonal antibodies in allograft transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of rejection of kidney transplants by monoclonal antibody directed against interleukin 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin 2 receptor-targeted therapy--rationale and applications in organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation antigen expression on human T cells. I. Analysis by two-colour flow cytometry of umbilical cord blood, adult blood and lymphoid tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunological effects of the anti-IL-2 receptor monoclonal antibody BT 563 in liver allografted patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged action of a chimeric interleukin-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunoprophylaxis with a monoclonal anti-IL-2 receptor antibody in liver transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequent anti-V-region immune response to mouse B72.3 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Tacrolimus: a new immunosuppressive agent.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Posttransplantation lymphoproliferative disorder in patients under primary tacrolimus (FK 506) immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes as a complication of tacrolimus (FK506) in pediatric renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of the IL-2 receptor gamma chain on various populations in human peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The diagnosis and treatment of posttransplant lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphoproliferative disease in organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2897%2909278-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(97)09278-7

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652559

release_2tsebeo4azbuxjb3iemtve6ptq

1 reference

https://api.fatcat.wiki/v0/release/2tsebeo4azbuxjb3iemtve6ptq

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9652559

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47887130&oldid=1838611410"